4//SEC Filing
Lieu Hsiao D 4
Accession 0001415889-24-001544
CIK 0001426332other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 6:03 PM ET
Size
5.2 KB
Accession
0001415889-24-001544
Insider Transaction Report
Form 4
Lieu Hsiao
SVP, Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-01-16$1.34/sh−5,430$7,276→ 54,254 total
Footnotes (2)
- [F1]Represents shares withheld by the issuer to satisfy the tax obligation realized in connection with the vesting of restricted stock units previously reported in Table 1.
- [F2]Includes 3,717 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on May 15, 2023 and 362 ESPP shares acquired on November 15, 2023.
Documents
Issuer
NGM BIOPHARMACEUTICALS INC
CIK 0001426332
Entity typeother
Related Parties
1- filerCIK 0001468482
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 6:03 PM ET
- Size
- 5.2 KB